PTX-022
PALV-06
Phase 2 small_molecule completed
Quick answer
PTX-022 for Microcystic Lymphatic Malformation is a Phase 2 program (small_molecule) at PALVELLA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PALVELLA THERAPEUTICS, INC.
- Indication
- Microcystic Lymphatic Malformation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed